Avita Medical | 1811094D - Ebitda


Avita Medical reported AUD-9.69M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Accuray USD -685K 900K Sep/2024
Celltrion KRW 19.64B 1.85B Mar/2026
Clinuvel Pharmaceuticals AUD 27.55M 12.65M Jun/2025
Cochlear AUD 306.4M 13.5M Dec/2025
CSL USD 3.13B 1.17B Dec/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -46.46M 6.27M Mar/2026
Divis Laboratories Ltd INR 12.62B 3.28B Jun/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Mayne Pharma AUD 20.9M 5.2M Jun/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Nanosonics AUD 12.49M 1.13M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Organigram Holdings CAD -4.76M 10.02M Mar/2026
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
Pharma Mar EUR 700K 2.01M Jun/2026
Polynovo AUD 3.89M 100K Dec/2025
PYC Therapeutics AUD -22.79M 1.5M Dec/2025
Qiagen NV USD 207.66M 59.56M Jun/2026
Ramsay Health Care AUD 1.12B 10.6M Dec/2025
ResMed USD 568.84M 21.36M Mar/2026
Sartorius EUR 280.5M 13.2M Jun/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Telix Pharmaceuticals AUD 76.49M 58.07M Jun/2026
Tilray USD 8.36M 1.82M Sep/2025
Zealand Pharma A/S -379M 348.47M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026